Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Spondylarthropathies 1 Smoldering Multiple Myeloma 1 Rectal Neoplasms 1 Psoriasis 1 Multiple Sclerosis 1 Low Anterior Resection Syndrome 1 Liver Neoplasms 1 Inflammatory Bowel Diseases 1 Hematopoietic and Lymphatic System Neoplasm 1 Healthy Subject 1 Crohn Disease 1 Colitis, Ulcerative 1 Benign Colorectal Neoplasm 1 Autoimmune Diseases 1 Arthritis, Rheumatoid 1 Arthritis, Psoriatic 1

Interventions

Dexamethasone 14 Lenalidomide 13 Calcium Dobesilate 7 carfilzomib 4 dexamethasone acetate 3 dexamethasone 21-phosphate 3 auricularum 3 Melphalan 3 Leflunomide 3 Curcumin 3 isatuximab 2 iberdomide 2 daratumumab 2 Denosumab 2 Cyclophosphamide 2 Bortezomib 2 selinexor 1 pomalidomide 1 poly ICLC 1 piperine 1 pembrolizumab 1 ixazomib 1 ibrutinib 1 fludarabine phosphate 1 fludarabine 1 elotuzumab 1 citarinostat 1 atezolizumab 1 Urination 1 Transplantation, Autologous 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Smoldering Multiple Myeloma × Dietary Fiber × Clear all

NCT07069751 2026-04-03

HiFi-MM

IRCCS San Raffaele

Phase NA Recruiting

Smoldering Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡